Clostridioides difficile, formerly known as Clostridium difficile, is a bacterium notorious for causing severe gastrointestinal infections, often in healthcare settings. This resilient pathogen thrives in environments altered by antibiotic use, disrupting the balance of gut microbiota and allowing C. difficile to proliferate and produce toxins. The resulting infection, known as C. difficile-associated disease (CDAD), manifests as diarrhea, abdominal pain, and, in severe cases, life-threatening complications such as pseudomembranous colitis and toxic megacolon. Managing CDAD poses significant challenges due to the bacterium's ability to form resilient spores, making it resistant to many standard disinfection methods. Prevention and control strategies, including stringent hand hygiene practices, judicious antibiotic use, and environmental decontamination, are essential for combating C. difficile infections and reducing their impact on patient outcomes and healthcare systems.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation